Moberg Pharma — Major Shareholding Notification 2017

Dec 27, 2017

Issuer Moberg Pharma AB (publ)

Holder

Armistice Capital LLC (Delaware US LLC)

Instrument

Instrument	Shares SE0003613090
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Buy
Date	09/03/2017
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	876,000
Directly held voting rights	0
Indirectly held voting rights	876,000
Percentage
Directly held shares	5.03106 %
Directly held voting rights	0 %
Indirectly held voting rights	5.03106 %

Resulting distribution of total holdings

			Percentage of voting rights:	Number of underlying shares:
Shares			5.03106 %	876,000
	Instruments - FITA Ch. 4, section 2, first paragraph, line 2
	Instruments - FITA Ch. 4, section 2, first paragraph, line 3
	- Physically settled
- Cash settled
Total			5.03106 %	876,000
	Chain of controlling companies Voting rights % Voting rights Company
876,000	5.03106		Armistice Capital Master Fund
	Group total holdings
Voting rights		876,000
	Percentage of voting rights 5.03106
Published
	27/12/2017 12:16
Contact
Name	Anthony Cordone
Phone	212 231-4932 Email acordone@armisticecapital.com

*Source of information has chosen not to submit the data

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25